High-level expression of the FOXP1 fork head transcription factor is associated with the ABC-DLBCL subtype and has been correlated with a poor response to CHOP and R-CHOP therapy in multiple studies (10). The gene discussed is FOXP1; the disease is diffuse large B-cell lymphoma.